HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Hitoshi Koyanagi Akimasa Hashimoto Chisato Nojiri Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Nakano, K. Articles by Nojiri, C. Search for Related Content PubMed PubMed Citation Articles by Nakano, K. Articles by Nojiri, C.

J Thorac Cardiovasc Surg 1994;108:888-892
© 1994 Mosby, Inc.

SURGERY FOR ACQUIRED HEART DISEASE

Tricuspid valve replacement with the bileaflet St. Jude Medical valve prosthesis

Tokyo, Japan

From the Department of Cardiovascular Surgery, The Heart Institute of Japan, Tokyo Women's Medical College, 8-1 Kawada-cho Shinjuku-ku, Tokyo 162, Japan.

Received for publication Feb. 10, 1994. Accepted for publication June 16, 1994. Address for reprints: Hitoshi Koyanagi, MD, Department of Cardiovascular Surgery, The Heart Institute of Japan, Tokyo Women's Medical College, 8-1 Kawada-cho, Shinjuku-ku, Tokyo 162, Japan.

Abstract

Case histories of 39 patients who underwent tricuspid valve replacement with the St. Jude Medical prosthesis between June 1979 and August 1992 were reviewed in March 1993. The average patient age at the time of the operation was 46 ± 11 years (range from 17 to 68 years). Concomitant mitral and/or aortic valve replacements were performed in 30 patients. All patients were given warfarin to maintain thrombotest between 10% to 25%. This number was between 2.8 to 1.6 times the control value in the International Normalized Ratio of prothrombin time. Three operative deaths occurred (7.7%). Among six late deaths, two patients died suddenly of unknown causes, and the remaining patient deaths were not valve-related. The actuarial survival rate at 14 years was 54.7%. Valve thrombosis occurred in one patient and was successfully treated with intravenous urokinase. This was the only valve-related complication (0.67%/patient-year). No reoperations were necessary in the tricuspid position. In conclusion, the St. Jude Medical valve is our choice of prosthesis for tricuspid valve replacement in adult patients who can receive proper anticoagulation therapy. (J THORACCARDIOVASCSURG1994;108:888-92)

This article has been cited by other articles:

				T. Guenther, C. Noebauer, D. Mazzitelli, R. Busch, P. Tassani-Prell, and R. Lange Tricuspid valve surgery: a thirty-year assessment of early and late outcome Eur. J. Cardiothorac. Surg., August 1, 2008; 34(2): 402 - 409. [Abstract] [Full Text] [PDF]

				R. J. Shemin Tricuspid Valve Disease Card. Surg. Adult, January 1, 2008; 3(2008): 1111 - 1128. [Full Text]

				T. H. Akay, B. Gultekin, S. Ozkan, E. Aslim, B. Saritas, A. Sezgin, and S. Aslamaci Triple-Valve Procedures: Impact of Risk Factors on Midterm in a Rheumatic Population Ann. Thorac. Surg., November 1, 2006; 82(5): 1729 - 1734. [Abstract] [Full Text] [PDF]

				B.-C. Chang, S.-H. Lim, G. Yi, Y. S. Hong, S. Lee, K.-J. Yoo, M. S. Kang, and B. K. Cho Long-Term Clinical Results of Tricuspid Valve Replacement Ann. Thorac. Surg., April 1, 2006; 81(4): 1317 - 1324. [Abstract] [Full Text] [PDF]

				F. Filsoufi, A. C. Anyanwu, S. P. Salzberg, T. Frankel, L. H. Cohn, and D. H. Adams Long-Term Outcomes of Tricuspid Valve Replacement in the Current Era Ann. Thorac. Surg., September 1, 2005; 80(3): 845 - 850. [Abstract] [Full Text] [PDF]

				N. A G Solomon, R. C H Lim, P. Nand, and K. J Graham Tricuspid Valve Replacement: Bioprosthetic or Mechanical Valve? Asian Cardiovasc Thorac Ann, June 1, 2004; 12(2): 143 - 148. [Abstract] [Full Text] [PDF]

				G. Rizzoli, I. Vendramin, G. Nesseris, T. Bottio, C. Guglielmi, and L. Schiavon Biological or mechanical prostheses in tricuspid position? a meta-analysis of intra-institutional results Ann. Thorac. Surg., May 1, 2004; 77(5): 1607 - 1614. [Abstract] [Full Text] [PDF]

				R. J. Shemin Tricuspid Valve Disease Card. Surg. Adult, January 1, 2003; 2(2003): 1001 - 1015. [Full Text]

				M. Kaplan, M. S. Kut, M. M. Demirtas, S. Cimen, and A. Ozler Prosthetic replacement of tricuspid valve: bioprosthetic or mechanical Ann. Thorac. Surg., February 1, 2002; 73(2): 467 - 473. [Abstract] [Full Text] [PDF]

				A. A. Mangoni, T. G. DiSalvo, G. J. Vlahakes, C. A. Polanczyk, and M. A. Fifer Outcome following isolated tricuspid valve replacement Eur. J. Cardiothorac. Surg., January 1, 2001; 19(1): 68 - 73. [Abstract] [Full Text] [PDF]

				H. Kawano, T. Oda, S. Fukunaga, E. Tayama, T. Kawara, A. Oryoji, and S. Aoyagi Tricuspid valve replacement with the St. Jude Medical valve: 19 years of experience Eur. J. Cardiothorac. Surg., November 1, 2000; 18(5): 565 - 569. [Abstract] [Full Text] [PDF]

				C. P. Ratnatunga, M.-B. Edwards, C. J. Dore, and K. M. Taylor Tricuspid valve replacement: UK heart valve registry mid-term results comparing mechanical and biological prostheses Ann. Thorac. Surg., December 1, 1998; 66(6): 1940 - 1947. [Abstract] [Full Text] [PDF]

				C. T. Bajzer, W. J. Stewart, D. M. Cosgrove, S. J. Azzam, K. L. Arheart, and A. L. Klein Tricuspid valve surgery and intraoperative echocardiography: Factors affecting survival, clinical outcome, and echocardiographic success J. Am. Coll. Cardiol., October 1, 1998; 32(4): 1023 - 1031. [Abstract] [Full Text] [PDF]

				K. Nakano, K. Eishi, Y. Kosakai, F. Isobe, Y. Sasako, S. Nagata, H. Ueda, Y. Kito, and Y. Kawashima TEN-YEAR EXPERIENCE WITH THE CARPENTIER-EDWARDS PERICARDIAL XENOGRAFT IN THE TRICUSPID POSITION J. Thorac. Cardiovasc. Surg., March 1, 1996; 111(3): 605 - 612. [Abstract] [Full Text]